NCT05663853View on ClinicalTrials.gov

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Trial Locations (4)

10029

Corinne Goldsmith Dickinson Center for MS, New York

20815

MedStar Health, Chevy Chase

21205

The Johns Hopkins University, Baltimore

44195

Mellen Center, Cleveland

Sponsors
All Listed Sponsors
lead

LAPIX Therapeutics Inc.

INDUSTRY

NCT05663853 - An Observational Biomarker Study in Multiple Sclerosis (MS) Patients | Biotech Hunter | Biotech Hunter